Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-26

Clinical Trial Update: Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated autologous cell therapy for stress urinary incontinence in men after prostate surgery; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous cell therapy for stress urinary incontinence

Snippet

Sponsor: Cook MyoSite | Conditions: Urinary Incontinence, Stress | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-26